These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21362739)

  • 1. Trends in human immunodeficiency virus incidence and risk behavior among injection drug users in montreal, Canada: a 16-year longitudinal study.
    Bruneau J; Daniel M; Abrahamowicz M; Zang G; Lamothe F; Vincelette J
    Am J Epidemiol; 2011 May; 173(9):1049-58. PubMed ID: 21362739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV infection and risk, prevention, and testing behaviors among injecting drug users -- National HIV Behavioral Surveillance System, 20 U.S. cities, 2009.
    Broz D; Wejnert C; Pham HT; DiNenno E; Heffelfinger JD; Cribbin M; Krishna N; Teshale EH; Paz-Bailey G;
    MMWR Surveill Summ; 2014 Jul; 63(6):1-51. PubMed ID: 24990587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995.
    Bluthenthal RN; Kral AH; Erringer EA; Edlin BR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(5):505-11. PubMed ID: 9715848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in risk factors for hiv seroconversion among injection drug users: a 10-year perspective.
    Strathdee SA; Galai N; Safaiean M; Celentano DD; Vlahov D; Johnson L; Nelson KE
    Arch Intern Med; 2001 May; 161(10):1281-8. PubMed ID: 11371255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal changes in risk factors associated with HIV seroconversion among injection drug users in eastern central Canada.
    Roy E; Richer I; Morissette C; Leclerc P; Parent R; Claessens C; Blanchette C; Alary M
    AIDS; 2011 Sep; 25(15):1897-903. PubMed ID: 21785319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study.
    Bruneau J; Lamothe F; Franco E; Lachance N; Désy M; Soto J; Vincelette J
    Am J Epidemiol; 1997 Dec; 146(12):994-1002. PubMed ID: 9420522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiperson use of syringes among injection drug users in a needle exchange program: a gene-based molecular epidemiologic analysis.
    Shrestha S; Smith MW; Broman KW; Farzadegan H; Vlahov D; Strathdee SA
    J Acquir Immune Defic Syndr; 2006 Nov; 43(3):335-43. PubMed ID: 16980914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal trends in the incidence of human immunodeficiency virus infection and risk behavior among injection drug users in Baltimore, Maryland, 1988-1998.
    Nelson KE; Galai N; Safaeian M; Strathdee SA; Celentano DD; Vlahov D
    Am J Epidemiol; 2002 Oct; 156(7):641-53. PubMed ID: 12244033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver.
    Craib KJ; Spittal PM; Wood E; Laliberte N; Hogg RS; Li K; Heath K; Tyndall MW; O'Shaughnessy MV; Schechter MT
    CMAJ; 2003 Jan; 168(1):19-24. PubMed ID: 12515780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV incidence among injecting drug users in New York City syringe-exchange programmes.
    Des Jarlais DC; Marmor M; Paone D; Titus S; Shi Q; Perlis T; Jose B; Friedman SR
    Lancet; 1996 Oct; 348(9033):987-91. PubMed ID: 8855855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C and HIV incidence and harm reduction program use in a conflict setting: an observational cohort of injecting drug users in Kabul, Afghanistan.
    Todd CS; Nasir A; Stanekzai MR; Fiekert K; Sipsma HL; Vlahov D; Strathdee SA
    Harm Reduct J; 2015 Oct; 12():22. PubMed ID: 26472126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enough sterile syringes to prevent HIV transmission among injection drug users in Montreal?
    Remis RS; Bruneau J; Hankins CA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S57-9. PubMed ID: 9663625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users.
    Levine OS; Vlahov D; Brookmeyer R; Cohn S; Nelson KE
    J Infect Dis; 1996 Mar; 173(3):579-83. PubMed ID: 8627020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A longitudinal study of syringe acquisition by Puerto Rican injection drug users in New York and Puerto Rico: implications for syringe exchange and distribution programs.
    Finlinson HA; Oliver-Vélez D; Deren S; Cant JG; Colón HM; Robles RR; Kang SY; Andía JF
    Subst Use Misuse; 2006; 41(9):1313-36. PubMed ID: 16861181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Greater drug injecting risk for HIV, HBV, and HCV infection in a city where syringe exchange and pharmacy syringe distribution are illegal.
    Neaigus A; Zhao M; Gyarmathy VA; Cisek L; Friedman SR; Baxter RC
    J Urban Health; 2008 May; 85(3):309-22. PubMed ID: 18340537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Who uses needle exchange? A study of injection drug users in treatment in San Francisco, 1989-1990.
    Hahn JA; Vranizan KM; Moss AR
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):157-64. PubMed ID: 9241116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An external evaluation of a peer-run "unsanctioned" syringe exchange program.
    Wood E; Kerr T; Spittal PM; Small W; Tyndall MW; O'Shaughnessy MV; Schechter MT
    J Urban Health; 2003 Sep; 80(3):455-64. PubMed ID: 12930883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baseline self-perceived risk of HIV infection independently predicts the rate of HIV seroconversion in a prospective cohort of injection drug users.
    Wood E; Li K; Miller CL; Hogg RS; Montaner JS; Schechter MT; Kerr T
    Int J Epidemiol; 2005 Feb; 34(1):152-8. PubMed ID: 15561747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harm reduction interventions, behaviours and associated health outcomes in France, 1996-2003.
    Emmanuelli J; Desenclos JC
    Addiction; 2005 Nov; 100(11):1690-700. PubMed ID: 16277629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes.
    Kerr T; Small W; Buchner C; Zhang R; Li K; Montaner J; Wood E
    Am J Public Health; 2010 Aug; 100(8):1449-53. PubMed ID: 20558797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.